AMEX:ARMP
Armata Pharmaceuticals, Inc.
- Stock
Last Close
2.21
25/09 13:50
Market Cap
96.89M
Beta: 0.54
Volume Today
450
Avg: 13.05K
PE Ratio
−2.27
PFCF: −2.59
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -58.41M - | 23.11M 139.56% | -516K 102.23% | -18.84M 3,550.78% | -12.84M 31.85% | -12.11M 5.67% | -19.48M 60.85% | -22.18M 13.87% | -23.16M 4.39% | -36.92M 59.43% | -69.05M 87.03% | |
depreciation and amortization | 82K - | 158K 92.68% | 330K 108.86% | 369K 11.82% | 374K 1.36% | 389K 4.01% | 1.35M 247.30% | 1.11M 17.54% | 1.17M 4.94% | 892K 23.70% | 972K 8.97% | |
deferred income tax | 43.19M - | -73K - | -556K 661.64% | -1.30M 134.17% | -328K 74.81% | -454K 38.41% | -432K 4.85% | -1.31M 202.78% | -171K 86.93% | |||
stock based compensation | 1.44M - | 1.94M 34.73% | 483K 75.05% | 2.00M 313.04% | 700K 64.91% | 478K 31.71% | 4.27M 793.51% | 3.48M 18.64% | 2.88M 17.06% | 3.10M 7.74% | 938K 69.79% | |
change in working capital | 1.05M - | -556K 152.80% | -158K 71.58% | 670K 524.05% | -457K 168.21% | 345K 175.49% | -2.19M 734.49% | -874K 60.07% | -3.22M 268.76% | 439K 113.62% | 39K 91.12% | |
accounts receivables | 15K - | -92K 713.33% | -25K 72.83% | 100K 500% | 381K 281% | -467K - | -2.43M 419.91% | 1.05M 143.37% | ||||
inventory | 595K - | 105K - | 467K - | 2.43M 419.91% | -1.05M 143.37% | |||||||
accounts payables | 210K - | -977K 565.24% | 296K 130.30% | 298K 0.68% | -838K 381.21% | 343K 140.93% | -1.37M 500.58% | 544K 139.59% | 184K 66.18% | 3.67M 1,891.85% | 39K 98.94% | |
other working capital | 233K - | 513K 120.17% | -429K 183.63% | 167K 138.93% | 2K - | -815K 40,850% | -1.42M 73.99% | -3.41M 140.27% | -3.23M 5.31% | -39K 98.79% | ||
other non cash items | 5.20M - | -37.22M 815.89% | -9.85M 73.54% | 5.77M 158.61% | 4.33M 24.95% | 1.84M 57.42% | 918K 50.22% | 628K 31.59% | 60K 90.45% | 171K 185% | 19.71M 11,427.49% | |
net cash provided by operating activities | -7.45M - | -12.57M 68.80% | -9.78M 22.20% | -10.59M 8.26% | -9.19M 13.19% | -9.38M 2.07% | -15.58M 66.08% | -18.27M 17.25% | -23.57M 29.04% | -32.48M 37.78% | -47.42M 46.00% | |
investments in property plant and equipment | -102K - | -1.20M 1,078.43% | -210K 82.53% | -279K 32.86% | -58K 79.21% | -44K 24.14% | -131K 197.73% | -824K 529.01% | -1.30M 58.25% | -2.21M 69.56% | -8.14M 268.34% | |
acquisitions net | 3.01M - | |||||||||||
purchases of investments | ||||||||||||
sales maturities of investments | ||||||||||||
other investing activites | 10K - | |||||||||||
net cash used for investing activites | -102K - | -1.20M 1,078.43% | -210K 82.53% | -279K 32.86% | -58K 79.21% | -44K 24.14% | 2.88M 6,638.64% | -824K 128.64% | -1.30M 58.25% | -2.21M 69.56% | -8.13M 267.89% | |
debt repayment | -117K - | -815K 596.58% | -717K - | |||||||||
common stock issued | 18.00M - | 12.38M - | 7.57M 38.91% | 9.36M 23.66% | 12.25M 30.91% | 9.97M 18.56% | 22.89M 129.50% | 26.32M 14.97% | 44.39M 68.67% | |||
common stock repurchased | -173K - | |||||||||||
dividends paid | -80K - | |||||||||||
other financing activites | 9M - | 396K - | 13K 96.72% | 130K 900% | 203K 56.15% | -1M 592.61% | 1.03M 203.40% | -801K 177.47% | -375K 53.18% | 53.99M 14,496.80% | ||
net cash used provided by financing activities | 27.00M - | 12.78M - | 7.21M 43.59% | 8.67M 20.28% | 12.45M 43.59% | 8.97M 27.92% | 23.21M 158.61% | 25.52M 9.94% | 44.02M 72.49% | 53.99M 22.66% | ||
effect of forex changes on cash | 41K - | |||||||||||
net change in cash | 19.49M - | -13.77M 170.66% | 2.79M 120.25% | -3.66M 231.19% | -579K 84.18% | 3.02M 622.45% | -3.73M 223.31% | 4.12M 210.35% | 639K 84.48% | 9.32M 1,359.15% | -1.57M 116.83% | |
cash at beginning of period | 862K - | 20.36M 2,261.37% | 6.58M 67.67% | 9.37M 42.38% | 5.71M 39.05% | 5.13M 10.14% | 10.46M 103.88% | 6.73M 35.65% | 10.85M 61.13% | 11.49M 5.89% | 20.81M 81.16% | |
cash at end of period | 20.36M - | 6.58M 67.67% | 9.37M 42.38% | 5.71M 39.05% | 5.13M 10.14% | 8.16M 58.94% | 6.73M 17.46% | 10.85M 61.13% | 11.49M 5.89% | 20.81M 81.16% | 19.24M 7.54% | |
operating cash flow | -7.45M - | -12.57M 68.80% | -9.78M 22.20% | -10.59M 8.26% | -9.19M 13.19% | -9.38M 2.07% | -15.58M 66.08% | -18.27M 17.25% | -23.57M 29.04% | -32.48M 37.78% | -47.42M 46.00% | |
capital expenditure | -102K - | -1.20M 1,078.43% | -210K 82.53% | -279K 32.86% | -58K 79.21% | -44K 24.14% | -131K 197.73% | -824K 529.01% | -1.30M 58.25% | -2.21M 69.56% | -8.14M 268.34% | |
free cash flow | -7.55M - | -13.77M 82.44% | -9.99M 27.46% | -10.87M 8.78% | -9.25M 14.89% | -9.43M 1.90% | -15.71M 66.70% | -19.09M 21.52% | -24.88M 30.30% | -34.69M 39.44% | -55.57M 60.17% |
All numbers in USD (except ratios and percentages)